We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Maternal Serum Screening?

Tricia Christensen
By
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Maternal serum screening consists of two different tests performed on pregnant mothers at different times during pregnancy that may help indicate greater or less likelihood of certain fetal birth defects. These tests are not diagnosis of birth defects — they could indicate the need for additional diagnostic testing or that further diagnosis is probably unnecessary. Screenings are non-invasive and may be preferred to starting out with more extensive and, in some cases, riskier diagnostic methods.

The first of the maternal serum screening tests has two elements and takes place between the 11th and 13th weeks of pregnancy. The first element is a blood test of the mother, usually collected in a lab. The second part is an ultrasound.

Maternal blood is evaluated for beta-HCG (human chorionic gonadotropin) levels and for PAPP-A (pregnancy associated plasma protein-A). Changes in these levels from expected norms may indicate increased risk for trisomy 18, Down syndrome, and congenital heart defects. Blood results are compared to ultrasound measurements of the back of the fetus’ neck, which, if increased in thickness, may suggest additional risk.

Should findings from a first trimester maternal serum screening suggest additional risk for fetal disorders, women could undergo amniocenteses, chorionic villus sampling or have a fetal echocardiogram a couple of months after testing. These additional diagnostic tests are needed because abnormal findings on a maternal serum screening can be false alarms. A suggestion of elevated risk for birth defects or genetic problems doesn’t mean a fetus is affected.

Some women have a first maternal serum screening with suggested abnormal findings and have a second test during the second trimester. Alternately, women may wait until the second trimester prior to having a screening, or they may not have one at all. The second screening is a triple test that measures different things. It looks at hcG, but also evaluates estradiol, and alpha-fetoprotein. A quad test, an alternative, measures one more hormone in maternal blood, called inhibin-A, increasing accuracy of test readings by about 10%-15%.

The second trimester maternal serum screening also evaluates other factors when considering risk for having a baby with certain birth defects or genetic issues. Number of previous births, maternal age, and maternal health are part of creating a ratio that suggests risk. Again, these tests do not prove birth defects exist. They only suggest risk amount based on test findings. On the other hand, consistent findings of first and second trimester testing may pretty reliably predict conditions like Down’s about 90-95% of the time.

Maternal serum screening is not required, and some women can relate horror stories of screenings that inaccurately suggested birth defects. Some expectant moms do like the option of having these tests because they may rule out need for more extensive diagnosis, though tests with normal findings may also be inaccurate. As more is learned, there is evidence that these tests are actually more accurate than supposed, and some scientists suggest greater refinements of such screenings may eventually render more invasive diagnostic tools unnecessary.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Tricia Christensen
By Tricia Christensen , Writer
With a Literature degree from Sonoma State University and years of experience as a The Health Board contributor, Tricia Christensen is based in Northern California and brings a wealth of knowledge and passion to her writing. Her wide-ranging interests include reading, writing, medicine, art, film, history, politics, ethics, and religion, all of which she incorporates into her informative articles. Tricia is currently working on her first novel.

Discussion Comments

Tricia Christensen

Tricia Christensen

Writer

With a Literature degree from Sonoma State University and years of experience as a The Health Board contributor, Tricia...
Learn more
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.